Essayer OR - Gratuit
AI does not just make clinical trials faster; t makes them smarter
Express Pharma
|April 2025
Santhosh AF, VP, Asia Pacific South & India, Medidata highlights how AI is improving the efficiency and speed of the clinical trial process from early drug discovery to data analysis and decision-making. He also explains Medidata's contributions towards a digital transformation of the clinical research landscape, in an interview with Kavita Jani
-

What are the major advancements in drug development research? What are the opportunities for India in the current landscape?
Drug development research has made remarkable progress globally, with India emerging as a key contributor. According to Deloitte, India's pharmaceutical research and development (R&D) market is estimated to expand to $130 billion by 2030, and the country is considered the third-largest global producer of drugs by volume").
The biggest shift we are seeing in drug development is the introduction and increasing adoption of advanced technologies, such as artificial intelligence (AI), data analytics, telemedicine, and wearables and sensor technologies. While still relatively in the early stages in India compared to other markets, we are already seeing great appetite on the ground and tremendous opportunities to revolutionise drug development research. Benefits of AI include accelerating insights by processing colossal amounts of data within seconds, a number that would take humans years to process, while telemedicine and wearables enable hybrid and decentralised trials which make them more accessible to participants.
What are the challenges in the current clinical trial landscape in India? How can they be tackled?
While the talent pool has grown, the industry still grapples with skill gaps and high attrition rates of around 30 per cent, higher than the global average of 12 per cent (1). One way to tackle attrition is through the incorporation of technology that will enable talent to do their work more efficiently, thereby helping to mitigate stress and burnout.
For example, AI can help automate time-consuming and traditionally manual tasks such as the collection, organisation, and analysis of data, minimising human error and providing real-time insights.
Cette histoire est tirée de l'édition April 2025 de Express Pharma.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Express Pharma

Express Pharma
Flexotherm Heating Tapes & Cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
October 2025

Express Pharma
DRIVING INDIA'S INNOVATION EDGE
Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma Inc's shift from generics to innovation and global leadership
16 mins
October 2025

Express Pharma
Al compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging Al across nearly every aspect of commercialisation, from market forecasting and personalised marketing to dynamic pricing and beyond. In this article, Neha Aathavale takes the pulse of the industry to explore who is taking note and how companies are beginning to put Al into action in their commercial operations
7 mins
October 2025

Express Pharma
PRIME NEO: New age doors from Gandhi Automation
Gandhi Automations presents the multi-composites, high-performance door PRIME NEO for clean environments. Complete Washable, Greater Sealing and Pressure Resistant.
1 mins
October 2025

Express Pharma
Unani Medicine: At crossroads of tradition and modernity
Manufacturers, academic institutions and research councils are working together to elevate Unani medicine through clinical validation and policy alignment with international standards, finds Swati Rana
7 mins
October 2025

Express Pharma
Single-Use Technologies in Biologics Manufacturing: Benefits, Challenges, and Growing Demand
The biopharmaceutical industry is increasingly adopting single-use technology (SUT) to achieve flexibility, cost efficiency, and faster time-to-market. Compared with stainless steel systems, SUT reduces capital investment, eliminates cleaning and sterilization steps, lowers contamination risk, and shortens production timelines.
1 min
October 2025

Express Pharma
Sustainable packaging with Romaco and Liveo Research
Recycable blister packs
3 mins
October 2025

Express Pharma
With India soon to be three times the population of the EU, it makes perfect sense to have manufacturing here
As part of Sweden's Focus Asia programme, a high-level SME delegation recently visited India to strengthen bilateral ties and explore collaborations across sectors including pharma, biotech and others. Building on the momentum of the \"Time for Sweden\" event, the visit underscored Sweden's commitment to innovation, sustainability, and co-creation with India. Among the delegation was Emil Alexander Byström, CEO of SpinChem AB, who in an interaction with Kalyani Sharma shared his insights on how advanced Swedish technologies like biocatalysis and the company's patented Rotating Bed Reactor (RBR) can accelerate India's pharma and biotech innovation journey while supporting sustainable growth.
3 mins
October 2025

Express Pharma
Cell therapy's next chapter: Industry embraces in-vivo innovation
Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that cell therapy is entering a bold new phase in 2025 as the industry shifts from complex, lab-based ex vivo CAR-T to faster, more accessible in vivo CAR-T innovations. This approach promises to expand access, lower costs, and potentially tackle solid tumors and autoimmune diseases
4 mins
October 2025

Express Pharma
Research misconduct ...can delay meaningful and reliable discoveries
Dr Gráinne McNamara, Research Integrity/Publication Ethics Manager, S. Karger AG explores how research misconduct, peer review fraud slow down pharma research. Of particular concern to India is the fact that India-based researchers constitute 5 per cent of articles in life sciences retracted between 1976-2023. India-based researchers also have one of the highest rates of retraction relative to the overall publication output. Over an email exchange with Viveka Roychowdhury, she details how publishers are now deploying AI tools, some of which contributed to the problem in the first place, to detect and avert fraudulent research submissions
6 mins
October 2025
Listen
Translate
Change font size